milrinone has been researched along with ACD-MPV in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone was started at an initial dose of 50 mcg/kg, followed by continuous infusion of 0." | 5.38 | Heart failure treated with low-dose milrinone in a full-term newborn. ( Janota, J; Sebková, S; Tomek, V; Zemanová, P, 2012) |
| "It is therefore important to avoid both hypoxemia and hyperoxemia in the management of PPHN." | 2.53 | Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates. ( Konduri, GG; Lakshminrusimha, S; Steinhorn, RH, 2016) |
| "Milrinone is a phosphodiesterase III inhibitor which induces pulmonary vasodilatation by its actions through a cyclic adenylate monophosphate mediated signaling pathway." | 2.46 | Milrinone for persistent pulmonary hypertension of the newborn. ( Bassler, D; Kirpalani, H; Kreutzer, K; McNamara, P, 2010) |
| "Milrinone was started at an initial dose of 50 mcg/kg, followed by continuous infusion of 0." | 1.38 | Heart failure treated with low-dose milrinone in a full-term newborn. ( Janota, J; Sebková, S; Tomek, V; Zemanová, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Dillard, J | 1 |
| Pavlek, LR | 1 |
| Korada, S | 1 |
| Chen, B | 1 |
| Imam, SS | 1 |
| El-Farrash, RA | 1 |
| Taha, AS | 1 |
| Saleh, GA | 1 |
| Choobdar, FA | 1 |
| Shahhosseini, P | 1 |
| Vahedi, Z | 1 |
| Khosravi, N | 1 |
| Khalesi, N | 1 |
| Ghassemzadeh, M | 1 |
| Qasim, A | 1 |
| Jain, SK | 1 |
| Mandell, E | 1 |
| Kinsella, JP | 1 |
| Abman, SH | 1 |
| Luecke, C | 1 |
| McPherson, C | 1 |
| Dempsey, E | 1 |
| Rabe, H | 1 |
| Lakshminrusimha, S | 1 |
| Konduri, GG | 1 |
| Steinhorn, RH | 2 |
| Latini, G | 1 |
| Del Vecchio, A | 1 |
| De Felice, C | 1 |
| Verrotti, A | 1 |
| Bossone, E | 1 |
| Bassler, D | 2 |
| Kreutzer, K | 1 |
| McNamara, P | 2 |
| Kirpalani, H | 2 |
| Sebková, S | 1 |
| Tomek, V | 1 |
| Zemanová, P | 1 |
| Janota, J | 1 |
| Choong, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Milrinone Versus Sildenafil in Treatment of PPHN in Neonates[NCT04391478] | Phase 1 | 40 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| Effectiveness of Nebulized Magnesium Sulfate Combined With Sildenafil Citrate in Persistent Pulmonary Hypertension of Newborn[NCT04898114] | Phase 1/Phase 2 | 40 participants (Anticipated) | Interventional | 2021-06-02 | Recruiting | ||
| Does Closed-loop Automated Oxygen Control During Mechanical Ventilation Reduce Hypoxic Events? A Randomised Controlled Crossover Study in Ventilated Infants[NCT05017727] | 31 participants (Actual) | Observational | 2021-10-05 | Completed | |||
| Does Closed-loop Automated Oxygen Control During Mechanical Ventilation Reduce the Duration of Supplementary Oxygen Treatment and the Amount of Time Spent in Hyperoxia? A Randomised Trial in Ventilated Infants Born at or Near Term[NCT05657795] | 40 participants (Anticipated) | Interventional | 2022-12-07 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for milrinone and ACD-MPV
| Article | Year |
|---|---|
Milrinone Use in Persistent Pulmonary Hypertension of the Newborn.
Topics: Cardiotonic Agents; Humans; Infant, Newborn; Milrinone; Persistent Fetal Circulation Syndrome; Vasoc | 2020 |
Persistent pulmonary hypertension of the newborn.
Topics: Bosentan; Epoprostenol; Humans; Hypertension, Pulmonary; Hypoxia; Infant; Infant, Newborn; Infant, P | 2021 |
Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
Topics: Bosentan; Humans; Infant, Newborn; Milrinone; Nitric Oxide; Oxygen Inhalation Therapy; Persistent Fe | 2017 |
The Use of Cardiotonic Drugs in Neonates.
Topics: Adrenal Cortex Hormones; Asphyxia Neonatorum; Cardiotonic Agents; Dobutamine; Dopamine; Heart Defect | 2019 |
Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
Topics: Administration, Inhalation; Animals; Extracorporeal Membrane Oxygenation; Humans; Hyperoxia; Hypoxia | 2016 |
Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
Topics: Administration, Inhalation; Animals; Extracorporeal Membrane Oxygenation; Humans; Hyperoxia; Hypoxia | 2016 |
Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
Topics: Administration, Inhalation; Animals; Extracorporeal Membrane Oxygenation; Humans; Hyperoxia; Hypoxia | 2016 |
Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
Topics: Administration, Inhalation; Animals; Extracorporeal Membrane Oxygenation; Humans; Hyperoxia; Hypoxia | 2016 |
Advances in Neonatal Pulmonary Hypertension.
Topics: Administration, Inhalation; Disease Management; Extracorporeal Membrane Oxygenation; Humans; Hydroco | 2016 |
Persistent pulmonary hypertension of the newborn: therapeutical approach.
Topics: Administration, Inhalation; Humans; Infant, Newborn; Milrinone; Nitric Oxide; Persistent Fetal Circu | 2008 |
Milrinone for persistent pulmonary hypertension of the newborn.
Topics: Humans; Infant, Newborn; Milrinone; Persistent Fetal Circulation Syndrome; Vasodilator Agents | 2010 |
2 trials available for milrinone and ACD-MPV
| Article | Year |
|---|---|
Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
Topics: Humans; Hypertension, Pulmonary; Infant, Newborn; Milrinone; Nitric Oxide; Persistent Fetal Circulat | 2022 |
Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: A randomized clinical trial.
Topics: Administration, Inhalation; Humans; Hypertension, Pulmonary; Infant, Newborn; Milrinone; Nitric Oxid | 2023 |
3 other studies available for milrinone and ACD-MPV
| Article | Year |
|---|---|
Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness.
Topics: Administration, Inhalation; Cohort Studies; Humans; Infant, Newborn; Milrinone; Nitric Oxide; Persis | 2022 |
Heart failure treated with low-dose milrinone in a full-term newborn.
Topics: Cardiotonic Agents; Female; Heart Failure; Humans; Infant, Newborn; Milrinone; Persistent Fetal Circ | 2012 |
Neonatal persistent pulmonary hypertension treated with milrinone: four case reports.
Topics: Administration, Inhalation; Animals; Female; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infa | 2006 |